About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Brain Cancer Clinical Trials in Dallas | 47 Studies

Clinical Trials Brain CancerDallas

Brain Cancer Clinical Trials in Dallas

Find 47 clinical trials for brain cancer near Dallas, Texas. Connect with research centers in your area.

All Brain Cancer trials nationwide All trials in Dallas

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 1-20 of 47 trials

RecruitingMaximum Tolerated Dose, Safety, and Efficacy of Rhenium Nanoliposomes in Recurrent Glioma (ReSPECT)This is a multi-center, sequential cohort, open-label, volume and dose escalation study of the safety, tolerability, and distribution of 186RNL given by convection enhanced…NCT01906385·Manhasset, New York and 2 others RecruitingSonocloud-9 in Association With Carboplatin Versus Standard-of-Care Chemotherapies (CCNU or TMZ) in Recurrent GBMThe brain is protected from any toxic or inflammatory molecule by the blood-brain barrier (BBB). This physical barrier is located at the level of the blood vessel walls.NCT05902169·Phoenix, Arizona and 55 others

Brain Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

CompletedCilengitide (EMD 121974) for Recurrent Glioblastoma Multiforme (Brain Tumor)This study will investigate clinical activity, safety, and tolerability of the anti-angiogenic compound cilengitide (EMD 121974) in the treatment of first recurrence of…NCT00093964·Birmingham, Alabama and 16 others

Active not recruitingDSC-MRI in Measuring rCBV for Early Response to Bevacizumab in Patients With Recurrent GlioblastomaThis phase II trial studies how well dynamic susceptibility contrast-enhanced magnetic resonance imaging (DSC-MRI) works in measuring relative cerebral blood volume (rCBV) for…NCT03115333·Phoenix, Arizona and 57 others

CompletedDevelopment of Strategies to Increase Enrollment in Clinical Trials for Children With CancerRATIONALE: Taking part in a clinical trial may help children with cancer receive more effective treatment.NCT00002485·Sacramento, California and 30 others

TerminatedMultiple Doses and Regimens of Cabozantinib in Subjects With Grade IV Astrocytic Tumors in First or Second RelapseThis study was conducted in subjects with grade IV astrocytic tumors (a type of cancer that can occur in the brain or spinal cord) in first or second relapse.NCT01068782·Birmingham, Alabama and 18 others

CompletedTipifarnib in Treating Patients With Recurrent or Progressive Malignant GliomaRATIONALE: Tipifarnib may stop the growth of tumor cells by blocking the enzymes necessary for tumor cell growth.NCT00005859·Los Angeles, California and 10 others

UnknownStudy of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain CancerThe primary purpose of the study is to determine the efficacy of an investigational therapy called DCVax(R)-L in patients with newly diagnosed GBM for whom surgery is indicated.NCT00045968·Birmingham, Alabama and 85 others

Active not recruitingA Study of Berubicin in Adult Subjects With Recurrent Glioblastoma MultiformeThis is an open-label, multicenter, randomized, parallel, 2-arm, efficacy and safety study.NCT04762069·Little Rock, Arkansas and 47 others

CompletedErlotinib in Treating Patients With Recurrent Malignant Glioma or Recurrent or Progressive MeningiomaPhase I/II trial to study the effectiveness of erlotinib in treating patients who have recurrent malignant glioma or recurrent or progressive meningioma.NCT00045110·Los Angeles, California and 6 others

CompletedSafety and Efficacy of Trans Sodium Crocetinate (TSC) With Radiation and Temozolomide in Newly Diagnosed GlioblastomaThis open-label study evaluated the safety and efficacy of TSC when dosed concomitantly with the standard of care (radiation therapy and temozolomide) for newly diagnosed…NCT01465347·Phoenix, Arizona and 17 others

CompletedPPX and Concurrent Radiation for Newly Diagnosed Glioblastoma Without MGMT MethylationTo obtain preliminary data in a randomized phase II study whether PPX/RT improves progression-free survival as compared to temozolomide/RT for patients with GBM without MGMT…NCT01402063·La Jolla, California and 8 others

CompletedValproic Acid, Radiation, and Bevacizumab in Children With High Grade Gliomas or Diffuse Intrinsic Pontine GliomaCurrently, there are few effective treatments for the following aggressive brain tumors: glioblastoma multiforme, anaplastic astrocytoma, gliomatosis cerebri, gliosarcoma, or…NCT00879437·Oklahoma City, Oklahoma and 5 others

CompletedStudy To Test the Safety and Efficacy of TVI-Brain-1 As A Treatment for Recurrent Grade IV GliomaTVI-Brain-1 is an experimental treatment that takes advantage of the fact that your body can produce immune cells, called 'killer' white blood cells that have the ability to kill…NCT01290692·Kansas City, Missouri and 3 others

Unknown131-I-TM-601 Study in Adults With Recurrent High-Grade GliomaThis drug is being developed to treat a type of brain cancer, glioma.NCT00114309·Birmingham, Alabama and 18 others

CompletedSU-101 Compared With Procarbazine in Treating Patients With Glioblastoma MultiformeRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00003293·Phoenix, Arizona and 34 others

CompletedBevacizumab and Erlotinib After Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or GliosarcomaRATIONALE: Monoclonal antibodies, such as bevacizumab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread.NCT00720356·Los Angeles, California and 8 others

CompletedBevacizumab With or Without Trebananib in Treating Patients With Recurrent Brain TumorsThis partially randomized phase II trial with a safety run-in component studies the side effects and how well bevacizumab given with or without trebananib works in treating…NCT01609790·Anchorage, Alaska and 243 others

CompletedSafety and Efficacy Study of SL-701, a Glioma-Associated Antigen Vaccine To Treat Recurrent Glioblastoma MultiformeThe purpose of this study is to determine the safety and efficacy of SL-701 as a treatment for recurrent glioblastoma multiform (GBM).NCT02078648·Birmingham, Alabama and 15 others

CompletedGene Therapy in Treating Patients With Recurrent Malignant GliomasRATIONALE: Inserting the gene for adenovirus p53 into a person's tumor may improve the body's ability to fight cancer.NCT00004041·San Francisco, California and 7 others

Page 1 of 3Next

Other Conditions in Dallas

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia